Published in AIDS Weekly, August 4th, 2003
"Gene therapy to treat primary and secondary CNS diseases, including neuro-AIDS, has not yet been effective," researchers in the United States noted. "New approaches to delivering therapeutic genes to the central nervous system are therefore required."
"Recombinant SV40 vectors (rSV40) transduce both dividing and quiescent cells efficiently," and so were tested by P. Cordelier and coauthors at Jefferson Medical College in Philadelphia "for their ability to deliver anti-HIV-1 transgenes to terminally...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.